EGTX — Egetis Therapeutics AB (publ) Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for Egetis Therapeutics AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	288	144	128	303	351
Net Total Accounts Receivable
Net Total Receivables	6.84	6.8	10.2	36.4	23.6
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	300	153	147	346	380
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.74	4.28	2.7	4.4	2.6
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	717	569	561	760	792
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	70.1	39.2	49.4	104	204
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	86.3	42.2	54.9	215	299
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	631	527	506	546	493
Total Liabilities & Shareholders' Equity	717	569	561	760	792
Total Common Shares Outstanding